Parkinson's Patients with Dyskinesia Switched from Immediate Release Amantadine to Open‐label ADS‐5102

BACKGROUND: ADS‐5102 (amantadine) extended release capsules (GOCOVRI™) are a treatment for dyskinesia in patients with Parkinson's disease (PD). ADS‐5102 reduced dyskinesia and OFF time in phase 3 controlled trials of up to six months. Amantadine immediate release (IR) is used for dyskinesia, b...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mov Disord Clin Pract
Main Authors: Isaacson, Stuart H., Fahn, Stanley, Pahwa, Rajesh, Tanner, Caroline M., Espay, Alberto J., Trenkwalder, Claudia, Adler, Charles H., Patni, Rajiv, Johnson, Reed
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2018
Fag:
Research Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5947645/
https://ncbi.nlm.nih.gov/pubmed/29780852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.12595
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker